Relay Therapeutics, Inc. RLAY Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s shares (basic)?
- Relay Therapeutics, Inc. (RLAY) reported shares (basic) of 179.8M in Q1 2026.
- How has Relay Therapeutics, Inc.'s shares (basic) changed year-over-year?
- Relay Therapeutics, Inc.'s shares (basic) increased by 6.3% year-over-year, from 169.2M to 179.8M.
- What is the long-term trend for Relay Therapeutics, Inc.'s shares (basic)?
- Over 2 years (2023 to 2025), Relay Therapeutics, Inc.'s shares (basic) has grown at a 18.5% compound annual growth rate (CAGR), from 487.8M to 684.5M.
- What does shares (basic) mean?
- The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.